Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension

Our results suggest that, despite similar clinical and disease-related parameters, SSc patients who develop PAH have an unfavorable metabolic profile able to cause an impaired production of metabolites with protective effects on endothelial cells.